Edward Kowalczyk

Dr. Edward Kowalczyk

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2013 in Molecules
Verified
Journal Article
Open access
PDF file
MSMonika Sienkiewicz
Monika Sienkiewicz
MŁMonika Łysakowska
Monika Łysakowska
MPMarta Pastuszka
Marta Pastuszka
WBWojciech Bienias
Wojciech Bienias
EKEdward Kowalczyk
Edward Kowalczyk
The considerable therapeutical problems of persistent infections caused by multidrug-resistant bacterial strains constitute a continuing need to find effective antimicrobial agents. The aim of this study was to demonstrate the activities of basil (Ocimum basilicum L.) and rosemary (Rosmarinus officinalis L.) essential oils against multidrug- resistant clinical strains of Escherichia coli. A detailed analysis was performed of the resistance of the drug to the strains and their sensitivity to the tested oils. The antibacterial activity of the oils was tested against standard strain Escherichia coli ATCC 25922 as well as 60 other clinical strains of Escherichia coli. The clinical strains were obtained from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from hospital equipment. The inhibition of microbial growth by both essential oils, presented as MIC values, were determined by agar dilution. Susceptibility testing to antibiotics was carried out using disc diffusion. The results showed that both tested essential oils are active against all of the clinical strains from Escherichia coli including extended-spectrum β-lactamase positive bacteria, but basil oil possesses a higher ability to inhibit growth. These studies may hasten the application of essential oils in the treatment and prevention of emergent resistant strains in nosocomial infections.

12 December 2014 in Molecules
Verified
Journal Article
Open access
PDF file
MSMonika Sienkiewicz
Monika Sienkiewicz
AGAnna Głowacka
Anna Głowacka
EKEdward Kowalczyk
Edward Kowalczyk
AWAnna Wiktorowska-Owczarek
Anna Wiktorowska-Owczarek
Marta Jóźwiak-BębenistaMarta Jóźwiak-Bębenista
Marta Jóźwiak-Bębenista
MŁMonika Łysakowska
Monika Łysakowska
Acinetobacter sp. represent an important cause of nosocomial infections. Their resistance to some antibiotics, their ability to survive on inanimate surfaces in the hospital environment and their ability to produce biofilms contributes to their virulence. The aim of the study was to determine the antibacterial properties of cinnamon, lavender and geranium essential oils against bacteria of the genus Acinetobacter isolated from several clinical materials and from the hospital environment. A comprehensive evaluation of the susceptibility of Acinetobacter sp. clinical strains to recommended antibiotics was performed. The constituents of cinnamon, lavender and geranium essential oils were identified by GC-FID-MS analysis, and their Minimal Inhibitory Concentrations (MICs) against tested clinical strains were determined by the micro-dilution broth method. In addition, the effects of essential oils on the viability of human microvascular endothelial cells (HMEC-1) and glioblastoma cell line (T98G) were evaluated. Cinnamon bark oil was the most active against clinical and environmental strains of Acinetobacter baumannii with MIC values ranging from 0.5 to 2.5 µL/mL. The MIC values for geranium oil were between 7.5 and 9.5 µL/mL, and between 10.5 and 13.0 µL/mL for lavender oil. These essential oils can be best employed in the fight against infections caused by bacteria from Acinetobacter genus as components of formulations for hygiene and disinfection of hospital environment.

5 February 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Łukasz ŁopusiewiczŁukasz Łopusiewicz
Łukasz Łopusiewicz
Paweł KwiatkowskiPaweł Kwiatkowski
Paweł Kwiatkowski
Emilia Zofia Drozłowska-SobierajEmilia Zofia Drozłowska-Sobieraj
Emilia Zofia Drozłowska-Sobieraj
PTPaulina Trocer
Paulina Trocer
MKMateusz Kostek
Mateusz Kostek
MSMonika Sienkiewicz
Monika Sienkiewicz
Preparation of biodegradable packaging materials and valorisation of food industry residues to achieve “zero waste” goals is still a major challenge. Herein, biopolymer-based (carboxymethyl cellulose—CMC) bioactive films were prepared by the addition, alone or in combination, of carvacrol and fungal melanin isolated from champignon mushroom (Agaricus bisporus) agro-industrial residues. The mechanical, optical, thermal, water vapour, and UV-Vis barrier properties were studied. Fourier-transform infrared (FT-IR) spectroscopy studies were carried out to analyse the chemical composition of the resulting films. Antibacterial, antifungal, and antioxidant activities were also determined. Both CMC/melanin and CMC/melanin/carvacrol films showed some antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. The addition of melanin increased the UV-blocking, mechanical, water vapour barrier, and antioxidant properties without substantially reducing the transparency of the films. The addition of carvacrol caused loss of transparency, however, composite CMC/melanin/carvacrol films showed excellent antioxidant activity and enhanced mechanical strength. The developed bioactive biopolymer films have a good potential to be green bioactive alternatives to plastic films in food packaging applications.

1 August 2014 in Burns
Verified
Journal Article
Closed access
MSMonika Sienkiewicz
Monika Sienkiewicz
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
AKAndrzej Kaszuba
Andrzej Kaszuba
EKEdward Kowalczyk
Edward Kowalczyk

3 February 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
IWIwona Wojciechowska-Koszko
Iwona Wojciechowska-Koszko
Paweł KwiatkowskiPaweł Kwiatkowski
Paweł Kwiatkowski
MSMonika Sienkiewicz
Monika Sienkiewicz
MKMateusz Kowalczyk
Mateusz Kowalczyk
EKEdward Kowalczyk
Edward Kowalczyk
BDBarbara Dolegowska
Barbara Dolegowska
Currently, serological tests for Lyme disease (LD), routinely performed in laboratories following the European Concerted Action on Lyme Borreliosis recommendations as part of two-stage diagnostics, are often difficult to interpret. This concerns both the generation of false positive and negative results, which frequently delay the correct diagnosis and implementation of appropriate treatment. The above problems result from both morphological and antigenic variability characteristics for the life strategy of the spirochete Borrelia burgdorferi sensu lato, a complicated immune response, and imperfections in diagnostic methods. The study aimed to check the reactivity of sera from 69 patients with confirmed infection with Epstein–Barr virus (EBV), cytomegalovirus (CMV) and BK virus (BKV) with Borrelia antigens used in serological tests: indirect immunofluorescence (IIFT), enzyme-linked immunosorbent (ELISA) and immunoblot (IB). In the group of patients infected with EBV, the highest percentage of positive/borderline anti-Borrelia IgM and IgG results was obtained in the following tests: IIFT (51.9% for IgM, 63.0% for IgG), ELISA (22.2% for IgM, 29.6% for IgG) and IB (11.1% for IgM, 7.4% for IgG). In the group of CMV-infected patients, the highest percentage of positive/borderline anti-Borrelia IgM results were obtained in the following tests: IB (23.1%), IIFT (15.4%) and ELISA (7.7%), while in the IgG class in the IIFT (15.4%), IB (11.5%) and ELISA (3.9%) tests. In the group of patients infected with BKV, the highest percentage of positive/borderline anti-Borrelia IgM results was obtained in the following tests: IIFT (25.0%), IB (25.0%) and ELISA (3.9%), and in the IgG class in the tests: IB (50.0%), IIFT (6.2%) and ELISA (6.2%). The native flagellin (p41) and OspC proteins were the most frequently detected Borrelia antigens in all studied groups of patients in both classes of antibodies. Similar to other authors, the study confirmed the fact that serological tests used in the diagnosis of LD have a high potential to generate false positive results in patients with active viral infections, which may be related to cross-reacting antibodies appearing during the most common polyclonal activation of T/B lymphocytes, activated by viral superantigens.

1 January 2015 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
MSMonika Sienkiewicz
Monika Sienkiewicz
AGAnna Głowacka
Anna Głowacka
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
AKAndrzej Kaszuba
Andrzej Kaszuba
AUAnna Urbaniak
Anna Urbaniak
EKEdward Kowalczyk
Edward Kowalczyk
Introduction : The spreading of bacterial antibiotic resistance among clinical strains of pathogenic bacteria has made investigators to search for other active antibacterial agents which could provide a valuable complement to the existing therapies. Aim: To determine the antibacterial...